Sign in / Join Now
ETFs & Funds
-7977 failed to cure Hep-
after 12 weeks. Big setback, and just after $11 billion Pharmasset purchase closed. Down 20% pre-mkt
Add a reply...
Latest StockTalks »
people get GILD breaking news and analysis by email alert.
Get email alerts on GILD »
Gilead Sciences, Inc.
Get latest price
From other sites
Gilead (GILD) Stock Lower, Citigroup: Hepatitis C Drug Sales Look Weak
at TheStreet (Fri, 12:34PM)
Gilead (GILD) Price Target Cut Amid Weak Outlook for HIV Drug Sales
at TheStreet (Wed, 11:24AM)
Kelly A. Kramer Joins Gilead Sciences' Board Of Directors
at TheStreet (Tue, 8:55AM)
European Commission Grants Marketing Authorization For Gilead's Once-Daily Truvada® For Reducing The Risk Of Sexually Acquired HIV-1
at TheStreet (Mon, 11:49AM)
Gilead Sciences (GILD) Stock Up, Piper Jaffray: Splitting Is 'Poor Idea'
at TheStreet (Aug 19, 2016)